Onyx is a liquid embolic system developed by Micro Therapeutics, Inc. It comprises ethylene-vinyl alcohol copolymer (EVOH) made from 48 mol/L ethylene and 52 mol/L vinyl alcohol, dissolved in dimethyl-sulfoxide (DMSO) and combined with 35% weight per volume micronized tantalum powder for radiopacity. Primarily used globally for treating cerebral and spinal arteriovenous malformations (AVMs), it also has applications in hypervascular tumors, peripheral AVMs, arteriovenous fistulas (AVFs), and endoleak treatment.